| Literature DB >> 23503604 |
António B Melo1, M Reza Razeghinejad, Neal Palejwala, Jonathan S Myers, Marlene R Moster, George L Spaeth, L Jay Katz.
Abstract
PURPOSE: To report the outcomes of two different surgical techniques for the repair of late onset bleb leakage following trabeculectomy.Entities:
Keywords: Bleb Leakage; Bleb Repair; Conjunctival Advancement; Trabeculectomy
Year: 2012 PMID: 23503604 PMCID: PMC3595588
Source DB: PubMed Journal: J Ophthalmic Vis Res ISSN: 2008-322X
Clinical data of patients undergoing bleb excision and conjunctival advancement (Group 1)
| Patient number | Age (year) | Diagnosis | Prior antimetabolite exposure | Additional surgical intervention | Pre-op IOP (mmHg) | Last visit IOP(mmHg) | Post-op antiglaucoma medications | Pre-op vision (LogMAR) | Post-op vision (LogMAR) | Follow-up (months) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 70 | POAG | - | 2 | 14 | 2 | 0.3 | 0.4 | 3 | |
| 2 | 60 | POAG | - | 10 | 16 | 4 | 0.5 | 0.4 | 39 | |
| 3 | 52 | POAG | - | 10 | 16 | 0 | 0.3 | 1 | 10 | |
| 4 | 28 | POAG | - | 11 | 20 | 4 | 0.1 | 0.2 | 16 | |
| 5 | 85 | POAG | - | 12 | 10 | 0 | 0.3 | 0.3 | 23 | |
| 6 | 79 | POAG | - | Pericardium graft Bleb revision for leakage | 3 | 19 | 2 | 0 | 0.1 | 29 |
| 7 | 52 | POAG | - | 12 | 16 | 2 | NA | NA | 6 | |
| 8 | 63 | POAG | MMC | 5 | 12 | 3 | 0.3 | 0.3 | 23 | |
| 9 | 40 | POAG | MMC | 6 | 5 | 0 | 0.2 | 0.3 | 16 | |
| 10 | 81 | NTG | MMC | 6 | 17 | 2 | 0.55 | 1 | 53 | |
| 11 | 68 | NTG | MMC | 15 | 12 | 1 | 0.4 | 1.3 | 2 | |
| 12 | 70 | POAG | MMC | 1 | 15 | 2 | 1 | 0.4 | 13 | |
| 13 | 72 | Chandler’s syndrome | MMC | Pericardium graft | 20 | 21 | 1 | 0.55 | 1.3 | 20 |
| 14 | 36 | POAG | 5-FU | Bleb revision for leakage | 11 | 13 | 2 | 0.1 | 0 | 37 |
POAG, primary open angle glaucoma; OD, right eye; OS, left eye; NTG, normal-tension glaucoma; MMC, mitomycin C; 5-FU, 5-Fluorouracil; pre-op, preoperative; post-op, postoperative; IOP, intraocular pressure; LogMAR, logarithm of minimum angle of resolution
Clinical data of patients undergoing bleb de-epithelialization and conjunctival advancement (Group2)
| Patient number | Age (years) | Diagnosis | Prior antimetabolite exposure | Additional surgical intervention | Pre-op IOP | Last visit IOP | Post-op antiglaucoma medications | Pre-op vision (LogMAR) | Post-op vision (LogMAR) | Follow-up (months) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 64 | PG | - | 8 | 13 | 1 | 0.2 | 0.3 | 3 | |
| 2 | 63 | POAG | - | Bleb revision for leakage | 2 | 10 | 0 | 0 | 0 | 22 |
| 3 | 59 | POAG | - | 10 | 13 | 1 | 0.1 | 0.2 | 4 | |
| 4 | 60 | POAG | MMC | 4 | 12 | 0 | 0.2 | 0.3 | 19 | |
| 5 | 61 | POAG | MMC | Bleb needling+5-FUinjection | 3 | 15 | 0 | 1.3 | 1.9 | 30 |
| 6 | 39 | Uveitic glaucoma | MMC | 14 | 19 | 1 | 2.8 | 2.8 | 46 | |
| 7 | 75 | POAG | MMC | Ahmed valve implantation | 9 | 21 | 0 | 1.3 | 1.9 | 14 |
PG, pigmentary glaucoma; POAG, primary open angle glaucoma; MMC, mitomycin C; 5-FU, 5-fluorouracil; pre-op, preoperative post-op, postoperative; IOP, intraocular pressure; LogMAR, logarithm of minimum angle of resolution
An incision was made in the posterior aspect of the bleb to redirect aqueous flow posteriorly
Figure 1Mean intraocular pressure at baseline and various postoperative visits in groups 1 (bleb excision with conjunctival advancement, 14 eyes) and 2 (bleb deepithelialization with conjunctival advancement, 7 eyes).
Figure 2Kaplan-Meier analysis of cumulative probability of success in group 1 (bleb excision and conjunctival advancement, 14) and group 2 (bleb deepithelialization and conjunctival advancement, 7).
Previous reports on treatment of late-onset bleb leaks
| Study | Design | Number of cases | Technique | Success rate | Success criteria | Mean follow-up(months) |
|---|---|---|---|---|---|---|
| Catoira et al 24 | Retrospective,non-comparative case series | 17 | Blebde-epithelialization with conj. advancement | 47% | Resolution ofleak with IOP ≥ 6 and ≤ 21 mmHg without meds | 15.6 |
| Harris et al 15 | Retrospective,non-comparative case series | 47 | Blebde-epithelialization with conj. autograft | 91.5% | No recurrenceslater than 1 month after surgery and no further surgicalintervention for glaucoma, with adequate IOP | 14 |
| Wadhwani et al 20 | Retrospective,non-comparative case series | 22 | Pedicle flap withbleb preservation, bleb excision with conj. advancement, blebexcision with free conj. autograft | 86% | IOP control with≤ 2 meds after one or more bleb revisions | 21 |
| Burnstein et al 19 | Retrospective,non-randomizedcomparative interventional trial | 34 | Blebde-epithelialization with conj. advancement | 79.4% | Resolution ofleak, IOP ≤ 21 mmHg and no significant complications | 22.9 |
| Al-Shahwan et al 12 | Retrospective,non-comparative case series | 34 | Bleb excision,conj. advancement | 58.8% | IOP ≤ 21 mmHgwithout meds | 36.2 |
| Rauscher et al 17 | Randomized,controlled trial | 15 | Bleb excision,conj. advancement | 73.3% | No additionalsurgery needed (glaucoma or bleb revision) and controlled IOP | 79 |
| 15 | Bleb excision,AMT | 53.3% | 80 | |||
| Nagai-Kusuhara etal 18 | Retrospective,non-comparativecase series | 6 | AMT-assisted blebrevision | 100% | Resolution ofleak with adequate IOP | 49 |
median; conj., conjunctiva; IOP, intraocular pressure; AMT, amniotic membrane transplantation